Annual report pursuant to Section 13 and 15(d)

Schedule II-Consolidated Valuation and Qualifying Accounts and Reserves

v3.21.1
Schedule II-Consolidated Valuation and Qualifying Accounts and Reserves
12 Months Ended
Dec. 31, 2020
Valuation And Qualifying Accounts [Abstract]  
Schedule II-Consolidated Valuation and Qualifying Accounts and Reserves

BIOLASE, INC.

Schedule II — Consolidated Valuation and Qualifying Accounts and Reserves

For the Years Ended December 31, 2020, 2019, and 2018

(in thousands)

 

 

 

Balance at

 

 

Charges

 

 

 

 

 

 

 

 

 

 

 

Beginning

 

 

(Reversals) to Cost

 

 

 

 

 

 

Balance at

 

 

 

of Year

 

 

or Expenses

 

 

Deductions

 

 

End of Year

 

Year Ended December 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for doubtful accounts

 

$

2,531

 

 

$

1,488

 

 

$

(2

)

 

$

4,017

 

Allowance for sales returns

 

 

210

 

 

 

87

 

 

 

(35

)

 

$

262

 

Allowance for tax valuation

 

 

53,222

 

 

 

2,813

 

 

 

 

 

$

56,035

 

Year Ended December 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for doubtful accounts

 

$

850

 

 

$

1,827

 

 

$

(146

)

 

$

2,531

 

Allowance for sales returns

 

 

210

 

 

 

 

 

 

 

 

 

210

 

Allowance for tax valuation

 

 

46,967

 

 

 

6,366

 

 

 

(111

)

 

 

53,222

 

Year Ended December 31, 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for doubtful accounts

 

$

802

 

 

$

469

 

 

$

(421

)

 

$

850

 

Allowance for sales returns

 

 

210

 

 

 

 

 

 

 

 

 

210

 

Allowance for tax valuation

 

 

40,866

 

 

 

6,101

 

 

 

 

 

 

46,967